Cargando…

Structural and spectral investigations of the recently synthesized chalcone (E)-3-mesityl-1-(naphthalen-2-yl) prop-2-en-1-one, a potential chemotherapeutic agent

BACKGROUND: Chalcones (1,3-diaryl-2-propen-1-ones, represent an important subgroup of the polyphenolic family, which have shown a wide spectrum of medical and industrial application. Due to their redundancy in plants and ease of preparation, this category of molecules has inspired considerable atten...

Descripción completa

Detalles Bibliográficos
Autores principales: Barakat, Assem, Al-Majid, Abdullah Mohammed, Soliman, Saied M, Mabkhot, Yahia Nasser, Ali, M, Ghabbour, Hazem A, Fun, Hoong-Kun, Wadood, Abdul
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4477317/
https://www.ncbi.nlm.nih.gov/pubmed/26106444
http://dx.doi.org/10.1186/s13065-015-0112-5
_version_ 1782377732926078976
author Barakat, Assem
Al-Majid, Abdullah Mohammed
Soliman, Saied M
Mabkhot, Yahia Nasser
Ali, M
Ghabbour, Hazem A
Fun, Hoong-Kun
Wadood, Abdul
author_facet Barakat, Assem
Al-Majid, Abdullah Mohammed
Soliman, Saied M
Mabkhot, Yahia Nasser
Ali, M
Ghabbour, Hazem A
Fun, Hoong-Kun
Wadood, Abdul
author_sort Barakat, Assem
collection PubMed
description BACKGROUND: Chalcones (1,3-diaryl-2-propen-1-ones, represent an important subgroup of the polyphenolic family, which have shown a wide spectrum of medical and industrial application. Due to their redundancy in plants and ease of preparation, this category of molecules has inspired considerable attention for potential therapeutic uses. They are also effective in vivo as anti-tumor promoting, cell proliferating inhibitors and chemo preventing agents. RESULTS: Synthesis and molecular structure investigation of (E)-3-mesityl-1-(naphthalen-2-yl) prop-2-en-1-one (3) is reported. The structure of the title compound 3 is confirmed by X-ray crystallography. The optimized molecular structure of the studied compound is calculated using DFT B3LYP/6-311G (d,p) method. The calculated geometric parameters are in good agreement with the experimental data obtained from our reported X-ay structure. The calculated IR fundamental bands were assigned and compared with the experimental data. The electronic spectra of the studied compound have been calculated using the time dependant density functional theory (TD-DFT). The longest wavelength band is due to H → L (79 %) electronic transition which belongs to π-π* excitation. The (1)H- and (13)C-NMR chemical shifts were calculated using gauge independent atomic orbitals (GIAO) method, which showed good correlations with the experimental data (R(2) = 0.9911–0.9965). The natural bond orbital (NBO) calculations were performed to predict the natural atomic charges at different atomic sites. The molecular electrostatic potential (MEP) was used to visualize the charge distribution on the molecule. Molecular docking results suggest that the compound might exhibit inhibitory activity against GPb and may act as potential anti-diabetic compound. CONCLUSIONS: (E)-3-Mesityl-1-(naphthalen-2-yl) prop-2-en-1-one single crystal is grown and characterized by single crystal X-ray diffraction, FT-IR, UV–vis, DFT and optimized geometrical parameters are close to the experimental bond lengths and angles. Molecular stability was successfully analyzed using NBO and electron delocalization is confirmed by MEP. Prediction of Activity Spectra Analysis of the title compound, predicts anti-diabetic activity with probability to have an active value of 0.348. [Figure: see text] ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13065-015-0112-5) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-4477317
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-44773172015-06-24 Structural and spectral investigations of the recently synthesized chalcone (E)-3-mesityl-1-(naphthalen-2-yl) prop-2-en-1-one, a potential chemotherapeutic agent Barakat, Assem Al-Majid, Abdullah Mohammed Soliman, Saied M Mabkhot, Yahia Nasser Ali, M Ghabbour, Hazem A Fun, Hoong-Kun Wadood, Abdul Chem Cent J Research Article BACKGROUND: Chalcones (1,3-diaryl-2-propen-1-ones, represent an important subgroup of the polyphenolic family, which have shown a wide spectrum of medical and industrial application. Due to their redundancy in plants and ease of preparation, this category of molecules has inspired considerable attention for potential therapeutic uses. They are also effective in vivo as anti-tumor promoting, cell proliferating inhibitors and chemo preventing agents. RESULTS: Synthesis and molecular structure investigation of (E)-3-mesityl-1-(naphthalen-2-yl) prop-2-en-1-one (3) is reported. The structure of the title compound 3 is confirmed by X-ray crystallography. The optimized molecular structure of the studied compound is calculated using DFT B3LYP/6-311G (d,p) method. The calculated geometric parameters are in good agreement with the experimental data obtained from our reported X-ay structure. The calculated IR fundamental bands were assigned and compared with the experimental data. The electronic spectra of the studied compound have been calculated using the time dependant density functional theory (TD-DFT). The longest wavelength band is due to H → L (79 %) electronic transition which belongs to π-π* excitation. The (1)H- and (13)C-NMR chemical shifts were calculated using gauge independent atomic orbitals (GIAO) method, which showed good correlations with the experimental data (R(2) = 0.9911–0.9965). The natural bond orbital (NBO) calculations were performed to predict the natural atomic charges at different atomic sites. The molecular electrostatic potential (MEP) was used to visualize the charge distribution on the molecule. Molecular docking results suggest that the compound might exhibit inhibitory activity against GPb and may act as potential anti-diabetic compound. CONCLUSIONS: (E)-3-Mesityl-1-(naphthalen-2-yl) prop-2-en-1-one single crystal is grown and characterized by single crystal X-ray diffraction, FT-IR, UV–vis, DFT and optimized geometrical parameters are close to the experimental bond lengths and angles. Molecular stability was successfully analyzed using NBO and electron delocalization is confirmed by MEP. Prediction of Activity Spectra Analysis of the title compound, predicts anti-diabetic activity with probability to have an active value of 0.348. [Figure: see text] ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13065-015-0112-5) contains supplementary material, which is available to authorized users. Springer International Publishing 2015-06-13 /pmc/articles/PMC4477317/ /pubmed/26106444 http://dx.doi.org/10.1186/s13065-015-0112-5 Text en © Barakat et al. 2015 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Barakat, Assem
Al-Majid, Abdullah Mohammed
Soliman, Saied M
Mabkhot, Yahia Nasser
Ali, M
Ghabbour, Hazem A
Fun, Hoong-Kun
Wadood, Abdul
Structural and spectral investigations of the recently synthesized chalcone (E)-3-mesityl-1-(naphthalen-2-yl) prop-2-en-1-one, a potential chemotherapeutic agent
title Structural and spectral investigations of the recently synthesized chalcone (E)-3-mesityl-1-(naphthalen-2-yl) prop-2-en-1-one, a potential chemotherapeutic agent
title_full Structural and spectral investigations of the recently synthesized chalcone (E)-3-mesityl-1-(naphthalen-2-yl) prop-2-en-1-one, a potential chemotherapeutic agent
title_fullStr Structural and spectral investigations of the recently synthesized chalcone (E)-3-mesityl-1-(naphthalen-2-yl) prop-2-en-1-one, a potential chemotherapeutic agent
title_full_unstemmed Structural and spectral investigations of the recently synthesized chalcone (E)-3-mesityl-1-(naphthalen-2-yl) prop-2-en-1-one, a potential chemotherapeutic agent
title_short Structural and spectral investigations of the recently synthesized chalcone (E)-3-mesityl-1-(naphthalen-2-yl) prop-2-en-1-one, a potential chemotherapeutic agent
title_sort structural and spectral investigations of the recently synthesized chalcone (e)-3-mesityl-1-(naphthalen-2-yl) prop-2-en-1-one, a potential chemotherapeutic agent
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4477317/
https://www.ncbi.nlm.nih.gov/pubmed/26106444
http://dx.doi.org/10.1186/s13065-015-0112-5
work_keys_str_mv AT barakatassem structuralandspectralinvestigationsoftherecentlysynthesizedchalconee3mesityl1naphthalen2ylprop2en1oneapotentialchemotherapeuticagent
AT almajidabdullahmohammed structuralandspectralinvestigationsoftherecentlysynthesizedchalconee3mesityl1naphthalen2ylprop2en1oneapotentialchemotherapeuticagent
AT solimansaiedm structuralandspectralinvestigationsoftherecentlysynthesizedchalconee3mesityl1naphthalen2ylprop2en1oneapotentialchemotherapeuticagent
AT mabkhotyahianasser structuralandspectralinvestigationsoftherecentlysynthesizedchalconee3mesityl1naphthalen2ylprop2en1oneapotentialchemotherapeuticagent
AT alim structuralandspectralinvestigationsoftherecentlysynthesizedchalconee3mesityl1naphthalen2ylprop2en1oneapotentialchemotherapeuticagent
AT ghabbourhazema structuralandspectralinvestigationsoftherecentlysynthesizedchalconee3mesityl1naphthalen2ylprop2en1oneapotentialchemotherapeuticagent
AT funhoongkun structuralandspectralinvestigationsoftherecentlysynthesizedchalconee3mesityl1naphthalen2ylprop2en1oneapotentialchemotherapeuticagent
AT wadoodabdul structuralandspectralinvestigationsoftherecentlysynthesizedchalconee3mesityl1naphthalen2ylprop2en1oneapotentialchemotherapeuticagent